← Back to Analyst Consensus 
ARTV Buy
Artiva Biotherapeutics, Inc.
Current Price —
Implied Upside —
Analysts 12
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 1 reiterations from 1 firms
Next Earnings
Nov 18, 2026 (23 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Oct 2, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | — | 50% |
| Jun 8, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| May 12, 2026 | Needham | maintain | Buy → Buy | — | 50% |
| May 11, 2026 | Cantor Fitzgerald | maintain | Overweight → Overweight | — | 50% |
| May 11, 2026 | Wedbush | maintain | Outperform → Outperform | — | 58% |
| May 8, 2026 | HC Wainwright & Co. | maintain | Buy → Buy | — | 44% |
| May 4, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Mar 11, 2026 | Needham | reiterate | Buy → Buy | — | 50% |
| Nov 12, 2025 | HC Wainwright & Co. | maintain | Buy → Buy | $15 | 44% |
| Oct 17, 2025 | Wedbush | maintain | Outperform → Outperform | $23 | 58% |
| Oct 17, 2025 | Needham | reiterate | Buy → Buy | $18 | 50% |
| May 15, 2025 | Needham | maintain | Buy → Buy | $18 | 50% |
| Apr 8, 2025 | Needham | reiterate | Buy → Buy | $23 | 50% |
| Mar 26, 2025 | HC Wainwright & Co. | reiterate | Buy → Buy | $20 | 44% |
| Mar 25, 2025 | Wedbush | reiterate | Outperform → Outperform | $18 | 58% |
| Mar 25, 2025 | Cantor Fitzgerald | maintain | Overweight → Overweight | $20 | 50% |
| Mar 25, 2025 | Needham | reiterate | Buy → Buy | $23 | 50% |
| Dec 30, 2024 | HC Wainwright & Co. | initiate | — → Buy | $20 | 44% |
| Nov 13, 2024 | Needham | reiterate | Buy → Buy | $23 | 50% |
| Aug 30, 2024 | Needham | reiterate | Buy → Buy | $23 | 50% |
| Aug 13, 2024 | Needham | initiate | — → Buy | $23 | 50% |
| Aug 13, 2024 | Wedbush | initiate | — → Outperform | $18 | 58% |
| Aug 13, 2024 | Cantor Fitzgerald | initiate | — → Overweight | $23 | 50% |
| Aug 13, 2024 | TD Cowen | initiate | — → Buy | $0 | 54% |
| Aug 13, 2024 | Jefferies | initiate | — → Buy | $21 | 52% |
Price Target Trend
May 28, 2026 Latest: $35.8 Oct 25, 2026
EPS Estimates
+1q $-0.58
Lo: $-0.65 Hi: $-0.54
5 analysts 0y $-2.51
Lo: $-2.63 Hi: $-2.30
5 analysts ▲1
+1y $-2.61
Lo: $-3.31 Hi: $-2.25
5 analysts ▲1
0q $-0.53
Lo: $-0.56 Hi: $-0.47
5 analysts Cross-Platform Signals
No cross-platform signals in the last 90 days